GlycoMimetics Inc (GLYC)
0.2337
+0.03
(+13.72%)
USD |
NASDAQ |
Dec 20, 16:00
0.23
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Shareholders Equity (Quarterly): 11.38M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 5.413B |
| Arbutus Biopharma Corp | 106.89M |
| Revance Therapeutics Inc | -163.03M |
| FibroGen Inc | -243.67M |
| Cidara Therapeutics Inc | 115.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.70M |
| Total Liabilities (Quarterly) | 4.322M |